Biblio

Author Title Type [ Year(Asc)]
Filters: Author is De Ravin, Suk See  [Clear All Filters]
2024
Castiello MCarmina, Brandas C, Ferrari S, Porcellini S, Sacchetti N, Canarutto D, Draghici E, Merelli I, Barcella M, Pelosi G, et al. Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency. Sci Transl Med. 2024;16(733):eadh8162.
2023
Yang AH, Sullivan B, Zerbe CS, De Ravin SSee, Blakely AM, Quezado MM, Marciano BE, Marko J, Ling A, Kleiner DE, et al. Gastrointestinal and Hepatic Manifestations of Chronic Granulomatous Disease. J Allergy Clin Immunol Pract. 2023.
2020
Lin CH, Kuehn HSun, Thauland TJ, Lee CM, De Ravin SSee, Malech HL, Keyes TJ, Jager A, Davis KL, Garcia-Lloret MI, et al. Progressive B Cell Loss in Revertant X-SCID. J Clin Immunol. 2020.
2019
Sweeney CL, Merling RK, De Ravin SSee, Choi U, Malech HL. Gene Editing in Chronic Granulomatous Disease. Methods Mol Biol. 2019;1982:623-665.
Mamcarz E, Zhou S, Lockey T, Abdelsamed H, Cross SJ, Kang G, Ma Z, Condori J, Dowdy J, Triplett B, et al. Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1. N Engl J Med. 2019;380(16):1525-1534.
2016
De Ravin SSee, Reik A, Liu P-Q, Li L, Wu X, Su L, Raley C, Theobald N, Choi U, Song AH, et al. Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease. Nat Biotechnol. 2016.
2014
De Ravin SSee, Su L, Theobald N, Choi U, Macpherson JL, Poidinger M, Symonds G, Pond SM, Ferris AL, Hughes SH, et al. Enhancers Are Major Targets for MLV Vector Integration. J Virol. 2014.